UK biotech industry elects new chairman
This article was originally published in SRA
UK biotech industry association BIA has elected as its new chairman Edward Hodgkin1. Dr Hodgkin, who is a partner at healthcare investment company Syncona Partners, will replace Tim Edwards when he formally steps down from the post on 30 October after serving as chairman for three years.
You may also be interested in...
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.